Springer

SHERPA: Unknown

People

  1. Robson
    Robson
  2. Offit
    Offit
  3. Hudis
    Hudis
  4. Dang
    Dang
  5. Hamilton
    Hamilton
  6. Morrow
    Morrow
  7. Norton
    Norton
  8. Amoroso
    Amoroso
  9. Hay
    Hay
  10. D'Andrea-Carlino
    D'Andrea-Carlino

Groups

  1. Breast Medicine Service (66)
  2. Department of Medicine (66)
  3. Population Sciences Research Program (66)
  4. Solid Tumor Oncology Division (66)
  5. Survivorship Research (66)
  6. Surgery (30)
  7. Epidemiology and Biostatistics (26)
  8. Clinical Genetics Service (24)
  9. GSK Faculty (24)
  10. Biostatistics Service (16)
Search Within
  1. "Mark Robson"
Formats
  1. Journal Article (38)
  2. Meeting Abstract (22)
  3. Miscellaneous (3)
  4. Review (2)
  5. Book Section (1)
Groups
  1. Breast Medicine Service (66)
  2. Department of Medicine (66)
  3. Population Sciences Research Program (66)
  4. Solid Tumor Oncology Division (66)
  5. Survivorship Research (66)
  6. Surgery (30)

More Groups

People
  1. Mark Robson (66)
  2. Kenneth Offit (22)
  3. Clifford Hudis (10)
  4. Larry Norton (10)
  5. Jada Hamilton (9)
  6. Chau Dang (8)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (7)
  4. 2022 (6)
  5. 2021 (3)
  6. 2020 (1)

More Years

Publications
  1. Breast Cancer Research and Treatment (33)
  2. Annals of Surgical Oncology (15)
  3. Annals of Behavioral Medicine (7)
  4. Familial Cancer (3)
  5. Advances in Therapy (1)
  6. Cancer Treatment and Research (1)

More Publications

Results (66)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds
    Journal Article

    Siddiqui, R.; Onel, K.; Facio, F.; Nafa, K.; Diaz, L. R.; Kauff, N.; Huang, H.; Robson, M.; Ellis, N.; Offit, K.
    Familial Cancer (2005)

    Fulltext@MSK | Save
  • Hereditary ovarian cancer in Ashkenazi Jews
    Journal Article

    Robles-Díaz, L.; Goldfrank, D.; Kauff, N.; Robson, M.; Offit, K.
    Familial Cancer (2004)

    Fulltext@MSK | Save
  • Impact of tamoxifen on the risk of metachronous contralateral breast cancer in women with germline mutations of BRCA1 or BRCA2
    Meeting Abstract

    Robson, M. E.; Satagopan, J.; Hudis, C. A.; Boyd, J.; Offit, K.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Combined estrogen blockade of the breast with raloxifene and exemestane in postmenopausal women for breast cancer prevention
    Meeting Abstract

    Dickler, M. N.; Robson, M. E.; Heerdt, A.; Dang, C.; Lake, D.; Moasser, M.; Bloch, R.; Ballon, D. J.; Morris, E. A.; Tan, L. K.; more...
    Breast Cancer Research and Treatment (2001)

    Fulltext@MSK | Save
  • Risk of ipsilateral recurrence (IBTR) and metachronous contralateral breast cancer (CBC) after breast conservation therapy (BCT) in women with germline BRCA1 or BRCA2 mutations
    Meeting Abstract

    Robson, M.; Roberge, D.; Satagopan, J.; Chappuis, P.; Boyd, J.; Offit, K.; Foulkes, W.
    Breast Cancer Research and Treatment (2000)

    Fulltext@MSK | Save